(PRWEB) March 17, 2005
Dermatologists at Royal London Hospital and nine other United Kingdom skin cancer treatment centres have supported claims that Curaderm-BEC cures skin cancer and is a viable alternative to conventional surgery, chemotherapy and laser treatments. Dermatologists applied the topical cream twice daily to the cancer lesion and within weeks, laboratory biopsies confirmed the BEC cream eliminated all traces of cancer. This startling discovery is a major medical breakthrough, as skin cancer is quickly becoming a health epidemic.
Skin cancer management usually involves surgery, and the risks of surgical intervention are well known. Excision of skin cancer, such as a Basel Cell Carcinoma (BCC), from the facial area often involves reconstructive surgery, which can be both time consuming and costly.
Dr. Sangeeta Punjabl of the Royal London Hospital concluded the Curaderm-BEC evaluation by stating, ÂWe consider that this rate of treatment success more than justifies the physician considering BEC as an alternative to currently predominant treatment such as surgical excision or cryotherapy.Â
The product consists of a patented biochemical (BEC) which is extracted from plants and a specialised cream formulation. Keratolytic and other agents in the cream soften and peel of the first layer of skin allowing the anti-cancer bio-chemical BEC to reach deep into the affected skin tissue. This active ingredient has an incredible capacity to select between cancerous and healthy cells. Once inside a cancer cell, the phytochemicals proceed to digest proteins, fats and carbohydrates, resulting in the destruction and sudden death of the cancer cell.
Clinical research and medical information available online at http://www.curaderm.net details over twenty years of medical evidence, including photographs of patient cases and other conclusive clinical data previously published in prestigious medical journals such as Cancer Letters and Drugs of Today. Over the past decade, similar successful claims have also been observed in independent studies by practicing doctors in the USA and Australia.
Curaderm-BEC can successfully eliminate all BCC's, SCC's and Keratosis in humans. Until now, Curaderm-BEC has been for sale exclusively in Australia, the skin cancer capital of the world, where over 50,000 consumers have chosen Curaderm-BEC to rid eliminate cancer lesions. The independent skin cancer clinicÂs positive conclusions are expected to provide further comfort to medical practitioners and consumers, proving that Curaderm-BEC is a safe skin cancer care alternative to surgery. Curaderm-BEC can be purchased and delivered to consumers worldwide at http://www.curaderm.net through the manufacturer Dr. Calmez Ltd.
Simon Agius, VP
# # #